Homologous regulation of the rat C1a calcitonin receptor (CTR) in nonosteoclastic cells is independent of CTR messenger ribonucleic acid changes and cyclic adenosine 3',5'-monophosphate-dependent protein kinase activation

Endocrinology

Volumn 137, Issue 11, 1996, Pages 4576-4585

  Findlay, D M ^a,b,c   Houssami, S ^a   Christopoulos, G ^a   Sexton, P M ^a,d  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Natl Hlth Med Res Cncl A   (Australia)

^c CCIPE   (France)

^d AUSTRALIAN RESEARCH COUNCIL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CALCITONIN RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION;

EID: 0029825377     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.11.8895320     Document Type: Article

References (56)

1. 2 on cyclic AMP formation in chicken and rat osteoclasts. J Cell Biochem 31:229-238
2. Azria M 1989 The Calcitonins: Physiology and Pharmacology. Karger, Basel
3. Lin HY, Harris TL, Flannery MS, Aruffo A, Kaji EH, Gorn A, Kolakowski LF, Lodish H, Goldring SR 1991 Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 254:1022-1024
4. Gorn AH, Lin HY, Yamin M, Auron FE, Flannery MR, Tapp DR, Manning CA, Lodish HF, Krane SM, Goldring SR 1992 Cloning, characterization and expression of a human calcitonin receptor from an ovarian carcinoma cell line. J Clin Invest 90:1726-1735
5. Kuestner RE, Elrod RD, Grant FJ, Hagen FS, Kuijper JL, Matthewes SL, O'Hara PJ, Sheppard PO, Stroop SD, Thompson DL, Whitmore TE, Findlay DM, Houssami S, Sexton PM, Moore EE 1994 Cloning and characterization of an abundant subtype of the human calcitonin receptor. Mol Pharmacol 46:246-255
6. Sexton PM, Houssami S, Hilton JM, O'Keeffe LM, Center RJ, Gillespie MT, Darcy P, Findlay DM 1993 Identification of brain isoforms of rat calcitonin receptor. Mol Endocrinol 7:815-821
7. Albrant K, Mull E, Brady EMG, Herich J, Moore CX, Beaumont K 1993 Molecular cloning of two receptors from rat brain with high affinity for salmon calcitonin. FEBS Lett 325:225-230
8. Yamin M, Gorn AH, Flannery MR, Jenkins NA, Gilbert DJ, Copeland NG, Tapp DR, Krane SM, Goldring SR 1994 Cloning and characterization of a mouse brain calcitonin receptor complementary deoxyribonucleic acid and mapping of the calcitonin receptor gene. Endocrinology 135:2635-2643
9. Shyu J-F, Baron R, Home WC 1995 Rabbit osteoclasts express two isoforms of the calcitonin receptor, one of which is novel. J Bone Miner Res 10:S486
10. Albrant K, Brady EMG, Moore CX, Mull E, Sierzega ME, Beaumont K 1995 Molecular cloning and functional expression of a third isoform of the human calcitonin receptor and partial characterization of the receptor gene. Endocrinology 136:5377-5384
11. Houssami S, Findlay DM, Brady CL, Myers DE, Martin TJ, Sexton PM 1994 Isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction. Endocrinology 135:183-190
12. Gorn AH, Rudolph SM, Flannery MR, Morton CC, Weremowicz S, Wang J-T, Krane SM, Goldring SR 1995 Expression of two skeletal calcitonin receptor isoforms cloned from a giant tumor of bone. The first intracellular domain modulates ligand binding and signal transduction. J Clin Invest 95:2680-2691
13. Moore EE, Keustner RE, Stroop SD, Grant FJ, Matthewes SL, Brody CJ, Sexton PM, Findlay DM 1995 Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcripts. Mol Endocrinol 9:959-968
14. Nussenveig DR, Mathew S, Gershengorn MC 1995 Alternative splicing of a 48-nucleotide exon generates two isoforms of the human calcitonin receptor. Endocrinology 136:2047-2051
15. Ikegame M, Rakopoulos M, Zhou H, Houssami S, Moseley JM, Martin TJ, Findlay DM 1994 Calcitonin receptor isoforms in mouse and rat osteoclasts. J Bone Miner Res 10:59-65
16. Houssami S, Findlay DM, Hilton JM, O'Keeffe LM, Martin TJ, Sexton PM 1994 Heterogeneity in ligand recognition of calcitonin receptors. Endocr J 2:127-134
17. Findlay DM, deLuise M, Michelangeli VP, Martin TJ 1981 Independent down-regulation of insulin and calcitonin receptors on a human tumour cell line. J Endocrinol 88:271-281
18. Lamp SJ, Findlay DM, Moseley JM, Martin TJ 1981 Calcitonin induction of a persistent activated state of adenylate cyclase in human breast cancer cells (T47D). J Biol Chem 256:12269-12274
19. Michelangeli VP, Findlay DM, Moseley JM, Martin TJ 1983 Mechanisms of calcitonin induction of prolonged activation of adenylate cyclase in human cancer cells. J Cyclic Nucleotide Protein Phosphor Res 9:129-142
20. Findlay DM, Ng KW, Niall M, Martin TJ 1982 Processing of calcitonin and epidermal growth factor after binding to receptors in human breast cancer cells (T47D). Biochem J 206:343-350
21. Findlay DM, Martin TJ 1984 Relationship between internalization and calcitonin-induced receptor loss in T47D cells. Endocrinology 115:78-83
22. Findlay DM, Martin TJ 1986 Kinetics of calcitonin receptor internalization in lung cancer (BEN) and osteogenic sarcoma (UMR 106-06) cells. J Bone Miner Res 1:277-283
23. Schneider H-G, Raue F, Bollenbach N, Scherubl H, Zeigler R 1990 Internalization of calcitonin receptors in primary rat kidney cell cultures. Acta Endocrinol (Copenh) 122:255-262
24. Wada S, Martin TJ, Findlay DM 1995 Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells. Endocrinology 136:2611-2621
25. Ikegame M, Ejiri S, Ozawa H 1994 Histochemical and autoradiographic studies on elcatonin internalization and intracellular movement in osteoclasts. J Bone Miner Res 9:25-37
26. Nicholson GC, Moseley JM, Yates AJ, Martin TJ 1987 Control of cyclic adenosine 3′,5′-monophosphate production in osteoclasts: calcitonin-induced persistent activation and homologous desensitization of adenylate cyclase. Endocrinology 120:1902-1908
27. Wada S, Udagawa N, Martin TJ, Findlay DM 1996 Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase A-mediated mechanism. Endocrinology 137:312-320
28. Okano K, Wu S, Huang X, Pirola CJ, Juppner H, Abou-Samura AB, Segre GV, Iwasaki K, Fagin JA, Clemens TL 1994 Parathyroid hormone (PTH)/ PTH-related protein (PTHrP) receptor and its messenger ribonucleic acid in rat aortic smooth muscle cells and UMR osteoblast-like cells: cell-specific regulation by angiotensin-II and PTHrP. Endocrinology 135:1093-1099
29. Abou-Samra AB, Zajac JD, Schiffer-Alberts D, Skurat R, Kearns A, Segre GV, Bringhurst FR 1991 Cyclic adenosine 3′,5′-monophosphate (cAMP)-dependent and cAMP-independent regulation of parathyroid hormone receptors on UMR 106-01 osteosarcoma cells. Endocrinology 129:2547-2554
30. Forrest SM, Ng KW, Findlay DM, Michelangeli VP, Livesey SA, Partridge NC, Zajac JD, Martin TJ 1985 Characterization of an osteoblast-like clonal cell line which responds to both parathyroid hormone and calcitonin. Calcif Tissue Int 37:51-56
31. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
32. Tso JY, Sun X-H, Kao T-h Reece KS, Wu R 1985 Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485-2502
33. Michelangeli VP, Findlay DM, Fletcher A, Martin TJ 1986 Calcitonin gene-related peptide (CGRP) acts independently of calcitonin on cyclic AMP formation in osteogenic sarcoma cells (UMR 106-01). Calcif Tissue Int 39:44-48
34. Houssami S, Findlay DM, Brady CL, Martin TJ, Epand RM, Moore EE, Murayama E, Tamura T, Orlowski RC, Sexton PM 1995 Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation. Mol Pharmacol 47:798-809
35. Rakopoulos M, Ikegame M, Findlay DM, Martin TJ, Moseley JM 1995 Short treatment of osteoclasts in bone marrow culture with calcitonin causes prolonged suppression of calcitonin receptor mRNA. Bone 17:447-453
36. Ikegame M, Rakopoulos M, Martin TJ, Moseley JM, Findlay DM 1996 Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor in mouse bone marrow cultures. J Bone Miner Res 11:456-465
37. Lee SK, Goldring SR, Lorenzo JA 1995 Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology 136:4572-4581
38. Takahashi S, Goldring S, Katz M, Hilsenbeck S, Williams R, Roodman GD 1995 Down-regulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation. J Clin Invest 95:167-171
39. Collins S, Bolanowski MA, Caron MG, Lefkowitz RJ 1989 Genetic regulation of β-adrenergic receptors. Annu Rev Physiol 51:203-215
40. Huber GK, Concepcion ES, Graves PN, Davies TF 1991 Positive regulation of human thyrotropin receptor mRNA by thyrotropin. J Clin Endocrinol Metab 72:1394-1396
41. Wiederkehr A, Caroni P 1995 Widely used enhancer of eukaryotic expression vectors is strongly and differentially regulated in fibroblast, myoblast, and teratocarcinoma cell lines. Exp Cell Res 219:664-670
42. Findlay DM, Michelangeli VP, Robinson PJ 1989 Protein kinase C-induced down-regulation of catcitonin receptors and calcitonin-activated adenylate cyclase in T47D and BEN cells. Endocrinology 125:2656-2663
43. Bouvier M, Leeb-Lundberg LMF, Benovic JL, Caron MG, Lefkowitz RJ 1987 Regulation of adrenergic receptor function by phosphorylation. II. Effects of agonist occupancy on phosphorylation of α1- and β2-adrenergic receptors by protein kinase C and the cyclic AMP-dependent protein kinase. J Biol Chem 262:3106-3113
44. Borner C, Eppenberger U, Wyss R, Fabbro D 1988 Continuous synthesis of two protein kinase C-related proteins after down-regulation by phorbol esters. Proc Natl Acad Sci USA 85:2110-2114
45. Wang H, Seagloff DL, Ascoli M 1991 Lutropin/choriogonadotropin down regulates its receptor by both receptor-mediated endocytosis and a cAMP-dependent reduction in receptor mRNA. J Biol Chem 266:780-785
46. Fukayama S, Schipani E, Juppner H, Lanske B, Kronenberg HM, Abou-Samra A-B, Bringhurst FR 1994 Role of protein kinase-A in homologous down-regulation of parathyroid hormone (PTH)/PTHrP-related peptide receptor messenger ribonucleic acid in human osteoblast-like SaOS-2 cells. Endocrinology 134:1851-1858
47. Kenakin T 1995 Agonist-receptor efficacy 2. Mechanisms of efficacy and receptor promiscuity. Trends Pharmacol Sci 16:188-192
48. 2-adrenergic receptor is constitutively desensitized and phosphorylated. Proc Natl Acad Sci USA 91:2699-2702
49. Blind E, Bambino T, Nissenson RA 1995 Agonist-stimulation phosphorylation of the G protein-coupled receptor for parathyroid hormone (PTH) and PTH-related protein. Endocrinology 136:4271-4277
50. Bliziotes MM 1995 Parathyroid hormone rapidly regulates β-adrenergic receptor kinase activity in cytosol of UMR 106-H5 cells. J Bone Miner Res 10:S483
51. Nygaard SC, Kuestner RE, Moore EE, Stroop SD 1995 Phosphorylation of the calcitonin receptor localized at the C-terminus. J Bone Miner Res 10:S141
52. Collins S, Caron MG, Lefkowitz RJ 1992 From ligand binding to gene expression: new insights into the regulation of G protein-coupled receptors. Trends Biochem Sci 17:37-39
53. Collins S, Lohse MJ, O'Dowd B, Caron MG, Lefkowitz RJ 1991 Structure and regulation of G protein-coupled receptors: the beta 2-adrenergic receptor as a model. Vitam Horm 46:1-39
54. Tezelman S, Shaver JK, Grossman RF, Liang W, Siperstein AE, Duh Q-Y, Clark OH 1994 Desensitization of adenylate cyclase in Chinese hamster ovary cells transfected with human thyroid-stimulating hormone receptor. Endocrinology 134:1561-1569
55. Chazenbalk GD, Nagayama Y, Kaufman KD, Rapoport B 1990 The functional expression of recombinant human thrytropin receptors in nonthyroidal eukaryotic cells provides evidence that homologous desensitization to thyrotropin stimulation requires a cell-specific factor. Endocrinology 127:1240-1244
56. 2-adrenergic receptor desensitization. Delineation with specific inhibitors. J Biol Chem 265:3202-3209